Haemonetics | HAE - Operating Expenses


Haemonetics reported $134.99M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Boston Scientific USD 4.2B 49M Jun/2026
Cerus USD 34.78M 2.98M Dec/2024
Cooper Companies USD 1.11B 301.2M Mar/2026
Fresenius EUR 5.23B 9M Jun/2026
Fresenius Medical Care EUR 4.34B 63M Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Intuitive Surgical USD 1.91B 3.6M Jun/2026
Medtronic USD 7.72B 436M Mar/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Neogen USD 222.2M 7.7M Mar/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Quidel USD 1.85B 1.09B Mar/2026
ResMed USD 925.74M 525K Mar/2026
STAAR Surgical USD 76.12M 7.38M Mar/2026
Steris USD 1.27B 51.5M Mar/2026
Stryker USD 4.8B 118M Jun/2026
Teleflex USD 3.08B 2.55B Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
US Physical Therapy USD 185.87M 86K Mar/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026